Analysis of plasma miR-208a and miR-370 expression levels for early diagnosis of coronary artery disease.

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 27602213)

Published in Biomed Rep on July 27, 2016

Authors

Hongsheng Liu¹, Ning Yang², Zhonghua Fei¹, Jie Qiu¹, Dongwen Ma¹, Xinmei Liu¹, Guoqiang Cai¹, Sheng Li³

Author Affiliations

1: Cardiac Intensive Care Unit, The Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.
2: Center of Health Management and Community Service, The Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.
3: Department of Biochemistry, Dalian Medical University, Dalian, Liaoning 116044, P.R. China.

Articles cited by this ↗

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27

MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59

Control of stress-dependent cardiac growth and gene expression by a microRNA. Science (2007) 12.08

Serum microRNAs are promising novel biomarkers. PLoS One (2008) 8.69

Circulating microRNAs in patients with coronary artery disease. Circ Res (2010) 6.28

A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell (2009) 5.28

Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J (2010) 5.04

MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest (2009) 4.39

Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res (2012) 4.06

Plasma miR-208 as a biomarker of myocardial injury. Clin Chem (2009) 3.61

Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol (2012) 3.20

Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation (2011) 2.52

Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology (2011) 1.67

MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res (2010) 1.56

Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease. PLoS One (2013) 1.19

Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarction. Int J Clin Exp Med (2014) 1.13

MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. J Am Heart Assoc (2014) 1.05

microRNA therapeutics in cardiovascular disease models. Annu Rev Pharmacol Toxicol (2013) 1.03

Circulating microRNAs (miR-423-5p, miR-208a and miR-1) in acute myocardial infarction and stable coronary heart disease. Minerva Cardioangiol (2013) 0.95

Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340* and miRNA624*. PLoS One (2011) 0.93

microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts. Cardiovasc Diagn Ther (2015) 0.89

microRNA regulation of lipoprotein metabolism. Curr Opin Lipidol (2014) 0.82

MicroRNAs 9 and 370 Association with Biochemical Markers in T2D and CAD Complication of T2D. PLoS One (2015) 0.80

Plasma miR-1, miR-208, miR-499 as potential predictive biomarkers for acute myocardial infarction: An independent study of Han population. Exp Gerontol (2015) 0.79

MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker. J Physiol Biochem (2015) 0.78